07:31 AM EDT, 08/13/2025 (MT Newswires) -- Tilray Brands ( TLRY ) on Wednesday said its Italian medical subsidiary, FL Group, has partnered with Molteni, an Italian pharmaceutical firm, to broaden the availability of Tilray Medical cannabis extracts for patients in Italy.

Molteni, which specializes in pain and substance dependence therapies, will also provide education to healthcare professionals on medical cannabis therapies through its network of pharmaceutical, scientific, and medical professionals throughout Italy.

"This partnership reflects our commitment to advancing patient care through strategic collaboration," said Rajnish Ohri, managing director, international at Tilray Brands ( TLRY ). "By combining FL Group's regulatory and distribution capabilities with Molteni's scientific leadership, we are not only expanding access to high-quality, EU-GMP certified cannabis therapies for patients across Italy but also prioritizing medical cannabis education for pain therapies."

Tilray is up US$0.02, to US$0.97, in New York trade.